Home/Filings/4/0001013762-23-000757
4//SEC Filing

Schuyler Kevin 4

Accession 0001013762-23-000757

CIK 0001513525other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 8:54 AM ET

Size

6.7 KB

Accession

0001013762-23-000757

Insider Transaction Report

Form 4
Period: 2023-09-29
Transactions
  • Purchase

    Common Stock

    2023-09-29$2.74/sh+700$1,918700 total
Holdings
  • Common Stock

    (indirect: By LLC)
    5,768
  • Common Stock

    (indirect: By Spouse)
    121
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.72 through $2.78, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F2]Mr. Schuyler has control over MVA 151 Investors, LLC.

Documents

1 file

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1
  • filerCIK 0001718094

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 8:54 AM ET
Size
6.7 KB